Allergy Therapeutics (AGY) — Defensive Interval Ratio
Allergy Therapeutics (AGY) has a Defensive Interval Ratio of 125 days as of December 2025. Defensive assets of GBX10.98 Million (cash GBX-, short-term investments GBX-, receivables GBX10.98 Million) cover 125 days of daily cash needs of GBX87.75K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Allergy Therapeutics Defensive Interval Ratio (2002–2025)
This chart shows how Allergy Therapeutics's Defensive Interval Ratio has evolved across 24 annual periods from 2002 to 2025. As of December 2025, the ratio stands at 125 days, meaning defensive assets of GBX10.98 Million can fund 125 days of operations without new revenue. For the complete balance sheet picture, see Allergy Therapeutics asset portfolio.
Annual Defensive Interval Ratio for Allergy Therapeutics (2002–2025)
The table below presents the year-by-year Defensive Interval Ratio for Allergy Therapeutics from 2002 to 2025, covering 24 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See working capital to net assets of Allergy Therapeutics to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (GBX) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 107 days | GBX7.97 Million | GBX74.50K/day | GBX- | GBX- | ▼ -36 days |
| 2024 | 143 days | GBX8.02 Million | GBX56.29K/day | GBX- | GBX200.00K | ▲ +3 days |
| 2023 | 139 days | GBX7.09 Million | GBX50.86K/day | GBX- | GBX- | ▼ -72 days |
| 2022 | 212 days | GBX10.47 Million | GBX49.46K/day | GBX- | GBX- | ▲ +87 days |
| 2021 | 125 days | GBX6.22 Million | GBX49.95K/day | GBX- | GBX- | ▼ -37 days |
| 2020 | 162 days | GBX8.08 Million | GBX49.94K/day | GBX- | GBX- | ▼ -50 days |
| 2019 | 212 days | GBX9.78 Million | GBX46.19K/day | GBX- | GBX- | ▲ +47 days |
| 2018 | 164 days | GBX6.59 Million | GBX40.08K/day | GBX- | GBX- | ▼ -9 days |
| 2017 | 174 days | GBX6.67 Million | GBX38.41K/day | GBX- | GBX404.00K | ▲ +314 days |
| 2016 | -140 days | GBX-4.81 Million | GBX34.30K/day | GBX- | GBX-10.33 Million | ▼ -338 days |
| 2015 | 197 days | GBX4.01 Million | GBX20.33K/day | GBX- | GBX783.00K | ▲ +11 days |
| 2014 | 187 days | GBX3.31 Million | GBX17.74K/day | GBX- | GBX345.00K | ▼ -73 days |
| 2013 | 260 days | GBX5.42 Million | GBX20.88K/day | GBX- | GBX2.00K | ▲ +60 days |
| 2012 | 200 days | GBX4.24 Million | GBX21.22K/day | GBX- | GBX483.00K | ▲ +12 days |
| 2011 | 188 days | GBX5.75 Million | GBX30.54K/day | GBX- | GBX- | ▲ +91 days |
| 2010 | 97 days | GBX2.66 Million | GBX27.35K/day | GBX- | GBX- | ▲ +59 days |
| 2009 | 38 days | GBX2.28 Million | GBX59.65K/day | GBX- | GBX- | ▼ -83 days |
| 2008 | 122 days | GBX2.70 Million | GBX22.21K/day | GBX- | GBX3.00K | ▲ +30 days |
| 2007 | 91 days | GBX2.71 Million | GBX29.76K/day | GBX- | GBX63.00K | ▼ -92 days |
| 2006 | 183 days | GBX2.48 Million | GBX13.53K/day | GBX- | GBX- | ▲ +16 days |
| 2005 | 168 days | GBX2.81 Million | GBX16.77K/day | GBX- | GBX- | ▼ -37 days |
| 2004 | 205 days | GBX1.84 Million | GBX8.98K/day | GBX- | GBX- | ▲ +35 days |
| 2003 | 170 days | GBX1.86 Million | GBX10.95K/day | GBX- | GBX- | ▲ +64 days |
| 2002 | 107 days | GBX1.34 Million | GBX12.58K/day | GBX- | GBX- | — |